l
voluntari
nonremuner
blood
donor
person
donat
blood
plasma
cellular
compon
hisher
free
receiv
payment
either
form
cash
kind
could
consid
substitut
money
l
familyreplac
blood
donor
person
give
replac
unit
blood
famili
member
friend
requir
transfus
l
paid
donor
donor
give
blood
money
form
payment
blood
screen
process
test
donat
blood
evid
infect
could
transmit
blood
blood
issu
transfus
patient
blood
transfus
servic
btss
gener
term
describ
blood
center
facil
involv
provis
blood
transfus
donor
select
process
assess
suitabl
individu
donat
blood
blood
compon
defin
select
criteria
incid
rate
occurr
new
case
particular
diseas
popul
studi
marker
infect
marker
infect
detect
sign
infect
appear
bloodstream
follow
infect
preval
proport
specif
popul
infect
infecti
agent
particular
time
transfusiontransmiss
infect
tti
infect
potenti
capabl
transmit
blood
transfus
blood
transfus
lifesav
intervent
essenti
role
patient
manag
within
health
care
system
respons
govern
ensur
safe
suffici
suppli
blood
avail
access
patient
requir
transfus
provis
safe
efficaci
blood
transfus
involv
number
process
includ
assess
suitabl
prospect
blood
donor
donat
blood
blood
collect
process
test
blood
donat
issu
blood
transfus
patient
whilst
blood
transfus
lifesav
associ
risk
particularli
transmiss
bloodborn
infect
includ
human
immunodefici
viru
hiv
baggaley
hepat
b
viru
hbv
hepat
c
viru
hcv
dwyre
et
al
microbi
agent
import
blood
transfus
servic
btss
transmiss
blood
transfus
caus
morbid
mortal
transfus
recipi
order
transmit
blood
transfus
infecti
agent
must
present
form
donat
blood
follow
characterist
l
presenc
agent
one
compon
blood
long
period
infecti
form
l
stabil
temperatur
whole
blood
blood
compon
store
l
long
incub
period
appear
clinic
sign
symptom
l
asymptomat
phase
mild
symptom
blood
donor
henc
alway
identifi
blood
donor
select
process
infecti
agent
meet
characterist
transmit
blood
transfus
howev
whether
transmiss
actual
occur
depend
number
factor
particularli
immun
statu
patient
amount
infecti
agent
transfus
larg
volum
blood
blood
compon
given
patient
transfus
therapi
even
blood
unit
low
viral
load
may
caus
infect
recipi
mani
virus
bacteria
protozoa
transmit
transfus
new
agent
potenti
transmit
transfus
continu
emerg
schmidt
et
al
infect
give
rise
specif
marker
circul
bloodstream
use
detect
identifi
infect
particular
infecti
agent
understand
biolog
infecti
agent
gener
particularli
transmiss
agent
import
determin
marker
infect
screen
particular
understand
time
infect
import
blood
screen
process
first
length
window
period
ie
time
infect
first
detect
defin
marker
infect
second
incub
period
ie
time
exposur
infect
onset
symptom
ill
donor
donat
window
period
gener
pose
greatest
threat
blood
safeti
despit
screen
infect
donat
may
detect
variou
marker
infect
appear
differ
time
infect
transfusiontransmiss
infect
tti
one
window
period
rang
day
month
depend
infecti
agent
screen
marker
use
screen
technolog
employ
period
recent
infect
individu
particular
screen
marker
yet
detect
even
though
individu
may
infecti
gener
follow
infect
nucleic
acid
infecti
agent
first
potenti
screen
marker
appear
follow
within
day
antigen
subsequ
antibodi
immun
respons
infecti
agent
develop
extent
rang
screen
perform
blood
suppli
vari
greatli
countri
countri
sometim
simpli
differ
countri
need
sometim
due
financi
constraint
result
effect
screen
program
also
vari
whatev
level
servic
provid
howev
main
purpos
screen
blood
ensur
avail
blood
suppli
free
possibl
infecti
agent
detect
marker
infect
may
present
blood
issu
transfus
infecti
agent
detect
directli
donat
blood
blood
often
screen
evid
infect
look
presenc
specif
antibodi
develop
infecti
agent
marker
infect
detect
presenc
agent
commonli
presenc
specif
antibodi
infecti
agent
although
develop
antibodi
demonstr
individu
immun
respons
infecti
agent
often
consid
reflect
immun
infecti
agent
case
mani
tti
case
rather
indic
presenc
infecti
agent
may
persist
indefinit
sequest
bodi
activ
inact
state
transmit
anoth
individu
may
give
rise
infect
one
combin
marker
infect
use
detect
particular
infect
screen
process
variou
assay
system
develop
blood
screen
detect
l
antibodi
indic
immun
respons
infecti
agent
l
antigen
produc
infecti
agent
indic
presenc
agent
l
nucleic
acid
rnadna
infecti
agent
bt
assess
potenti
risk
infecti
agent
infect
present
donor
popul
establish
system
donor
select
donat
test
defer
unsuit
blood
donor
donat
ensur
donat
blood
correctli
appropri
screen
specif
tti
key
point
rememb
transmiss
avoid
case
effect
donor
select
assess
donor
suitabl
blood
donat
screen
donat
blood
marker
tti
howev
time
introduct
biolog
materi
one
individu
anoth
never
without
risk
thing
zero
infect
risk
even
effect
blood
screen
still
risk
though
extrem
low
transmiss
infect
dodd
safest
blood
donor
gener
donat
voluntarili
regularli
without
remunerationvoluntari
nonremuner
donor
donor
highli
motiv
gener
lowest
level
risk
answer
donor
select
question
openli
honestli
donat
regularli
screen
regularli
would
quickli
identifi
infect
process
bt
therefor
strive
recruit
donor
base
voluntari
donor
provid
lowest
level
risk
convers
use
famili
replac
paid
donor
may
result
increas
risk
infect
encourag
regular
donat
although
basi
donor
suppli
number
countri
situat
encourag
world
health
organ
assess
donor
suitabl
blood
donat
prior
accept
donat
first
part
overal
screen
process
although
part
process
identifi
risk
donor
major
part
identifi
specif
factor
may
indic
donor
higher
risk
carri
infect
may
transmit
blood
transfus
safeti
blood
donat
may
thu
affect
donor
risk
exposur
hiv
hbv
hcv
syphili
tti
via
number
differ
rout
primarili
includ
infect
earli
life
antenat
perinat
close
contact
sexual
contact
percutan
exposur
highrisk
sexual
behavior
unsaf
blood
transfus
inject
practic
cosmet
treatment
ritual
current
previou
countri
resid
travel
histori
also
need
consid
number
transmiss
agent
restrict
geograph
therefor
threat
everi
donordon
donor
identifi
risk
defer
donat
either
temporarili
perman
depend
particular
risk
although
laboratori
screen
donat
evid
infecti
diseas
process
actual
determin
whether
donat
releas
use
donor
select
essenti
part
overal
screen
process
identifi
defer
unsuit
donor
donat
collect
thu
make
signific
contribut
ensur
safeti
donat
collect
screen
tti
exclud
blood
donat
risk
transmit
infect
donor
recipi
critic
part
process
ensur
transfus
safe
possibl
effect
screen
evid
presenc
common
danger
tti
reduc
risk
transmiss
low
level
howev
infecti
agent
found
certain
part
world
blood
screen
strategi
therefor
differ
endem
nonendem
region
bt
blood
bank
laboratori
therefor
perform
laboratori
screen
donat
evid
infect
specif
infecti
agent
present
popul
blood
donor
recruit
specif
screen
process
obvious
vari
depend
degre
develop
countri
health
care
system
number
donat
collect
infecti
agent
screen
countri
develop
health
care
system
screen
larg
autom
use
highli
sensit
specif
assay
perform
within
highli
control
system
howev
countri
less
welldevelop
health
care
system
lower
number
donat
manual
approach
use
nonetheless
good
qualiti
assay
use
standard
oper
procedur
follow
also
provid
effect
screen
system
whichev
screen
system
use
outcom
rel
straightforward
either
donat
neg
screen
reactiv
one
screen
assay
perform
donat
may
reactiv
initi
screen
depend
screen
strategi
adopt
may
consid
unsuit
clinic
use
point
howev
mani
transfus
servic
follow
strategi
requir
screen
reactiv
donat
initi
reactiv
retest
often
duplic
use
assay
still
reactiv
repeat
reactiv
donat
consid
unsuit
use
discard
neg
repeat
test
donat
consid
screen
neg
releas
clinic
use
nonreact
blood
blood
compon
issu
transfus
patient
everi
blood
screen
program
face
ongo
challeng
report
newli
identifi
infect
reemerg
infect
appear
regularli
scientif
literatur
includ
report
transmiss
rout
transfus
exampl
includ
variant
creutzfeldtjakob
diseas
ludlam
turner
wilson
et
al
west
nile
viru
stramer
babesiosi
cabl
leibi
dengu
teo
et
al
also
infect
theoret
risk
transmiss
case
transmiss
yet
identifi
proven
sever
acut
respiratori
syndrom
chikungunya
liumbruno
et
al
like
new
infect
identifi
may
transmiss
transfus
cautiou
measur
respons
need
appar
new
reemerg
threat
blood
safeti
bt
develop
conting
plan
ensur
surveil
emerg
infect
assess
transmiss
transfus
actual
likelihood
transmiss
diseas
associ
transmiss
action
taken
event
increas
incid
infect
includ
pandem
level
plan
also
address
potenti
effect
infect
donor
donor
suffici
potenti
recipi
bt
staff
health
care
staff
world
health
organ
essenti
subsequ
activ
confirm
screen
reactiv
result
critic
screen
reactiv
properli
fulli
investig
determin
true
infect
statu
donor
screen
program
gener
reactiv
result
case
blood
donat
screen
ensur
high
level
safeti
possibl
result
discard
donat
statu
donor
must
determin
decid
either
donor
truli
infect
must
refer
clinic
investig
manag
often
case
low
risk
donor
popul
screen
reactiv
nonspecif
donor
infect
may
still
abl
continu
donat
confirmatori
test
perform
must
therefor
abl
distinguish
true
infect
nonspecif
reactiv
number
reason
confirm
import
first
donor
truli
infect
clinic
intervent
may
requir
donor
contact
donor
need
protect
investig
appropri
second
donor
truli
infect
import
understand
donorsspecif
risk
donor
select
process
fail
identifi
donor
high
risk
defer
thirdli
screen
reactiv
proven
nonspecif
may
possibl
reinstat
donor
recal
futur
donat
unnecessari
loss
donor
due
nonspecif
screen
reactiv
accept
donor
valuabl
resourc
must
manag
effect
mani
case
nonspecif
reactiv
transient
also
may
assay
specif
screen
reactiv
low
risk
popul
nonspecif
clearli
potenti
perman
unnecessarili
lose
signific
number
suitabl
donor
donor
manag
correctli
adopt
blood
screen
strategi
appropri
need
infrastructur
resourc
countri
contribut
significantli
improv
blood
safeti
countri
effect
blood
screen
program
implement
risk
transmiss
tti
reduc
dramat
last
year
screen
follow
four
infect
transmiss
transfus
recommend
mandatori
provis
safe
blood
suppli
world
health
organ
infect
caus
chronic
diseas
possibl
seriou
consequ
present
greatest
infect
risk
recipi
transfus
l
human
immunodefici
viru
l
hepat
b
viru
l
hepat
c
viru
l
treponema
pallidum
syphili
importantli
risk
infect
virtual
elimin
screen
blood
donat
perform
qualityfocus
way
effort
made
implement
univers
screen
four
infect
countri
current
fulli
place
blood
donat
screen
least
one
suitabl
serolog
marker
four
infecti
